Legal & Compliance
1. Nature and Regulatory Status
1.1 What Fesera Is and Is Not
Fesera is a digital health and wellness platform providing guided, self-administered, evidence-based rehabilitation content for adults with chronic non-specific low back pain. It is not a medical device, a clinical service, or a licensed healthcare facility.
Fesera does not
- Diagnose medical conditions
- Prescribe pharmaceutical treatments
- Provide individual clinical consultations
- Create a therapeutic relationship with users
- Operate as a hospital or licensed clinic
Fesera does
- Provide clinician-designed movement protocols
- Use validated tools to screen for safety red flags
- Classify pain patterns to personalize general programs
- Provide evidence-grounded educational content
- Prompt users to seek professional care when indicated
1.2 Is Fesera a Medical Device?
The answer, under current applicable frameworks across all our markets, is no. Here is the reasoning:
- IMDRF SaMD Framework: The International Medical Device Regulators Forum (IMDRF) distinguishes between software that informs clinical management of an individual (regulated as SaMD) and software that provides general wellness information (not SaMD). Fesera provides a structured exercise programme for a population that has self-screened, positioning it as a general wellness tool.
- Nigeria (NAFDAC): Nigeria's regulatory framework for software-based digital health tools is developing. Fesera is not currently required to register as a medical device with NAFDAC.
- European Union (EU MDR 2017/745): Under MDCG 2019-11, general wellness software is not a medical device. Fesera falls into the general wellness category.
- United Kingdom (MHRA): Fesera's wellness and self-rehabilitation positioning aligns with MHRA's distinction between medical device software and general wellness tools.
- United States (FDA 21st Century Cures Act): Fesera falls within the enforcement discretion category for low-risk software that helps users self-manage a condition without providing specific treatment suggestions.
1.3 Nigerian Regulatory Compliance Summary
| Regulation | Compliance Status |
|---|---|
| NDPA 2023 (Data Protection) | Compliant (See Privacy Policy) |
| FCCPA 2018 (Consumer Protection) | Compliant transparent pricing and honest representations |
| NAFDAC Act (Medical Devices) | Wellness software classification; active regulatory tracking |
| PCN Act | Not a clinical practice; educational content only |
| CBN Payment Regulations | Compliant via Paystack payment engine |
2. Clinical Safety Framework
Fesera operates on a clinical safety first principle, with multiple gates built into the assessment and architecture:
- Red Flag Screening Gate: Mandatory screening before any exercise protocol is recommended. Positive screens redirect users to emergency medical evaluation.
- Condition Scope Gate: Tailored exclusively for chronic non-specific low back pain.
- Pain Response Telemetry: Daily check-in scores modify daily session intensity or trigger Rest advisories via a deterministic rules engine.
- In-Programme Red Flag Prompts: Urgent advisories if new symptoms emerge during check-ins.
- Phase Progression Gates: Users cannot progress without meeting defined clinical readiness criteria.
2.1 Contraindications
The programme is not appropriate for individuals with any of the following conditions:
- Active cancer or recent malignancy affecting the spine or adjacent structures
- Vertebral fracture (including osteoporotic compression fracture)
- Spinal infection (osteomyelitis, discitis, epidural abscess)
- Cauda equina syndrome
- Severe or rapidly progressive neurological deficit
- Ankylosing spondylitis or other inflammatory spondyloarthropathy requiring active management
- Recent spinal surgery without clearance from the treating surgeon (typically 6-12 weeks)
- Unstable cardiovascular condition contraindicating moderate physical activity
3. Professional Basis and Clinical Credentials
Fesera protocols are designed by licensed physiotherapists and informed by established, peer-reviewed clinical research:
| Tool / Framework | Application in Fesera |
|---|---|
| STarT Back Screening Tool (Keele University) | Psychosocial risk stratification |
| McKenzie Method (MDT) | Directional preference testing |
| McGill Method | Core endurance ratios & spine-sparing mechanics |
| Cochrane Collaboration (2021) | Evidence base for active movement therapy |
| ICD-10 M54.5 | Condition scope definition |
Note: Fesera is not formally affiliated with or accredited by the McKenzie Institute or any McGill-affiliated body. These frameworks are referenced based on published academic literature.
4. Platform Transparency: No AI Diagnosis
Fesera's classification and pain-response systems are rule-based algorithms, not artificial intelligence or machine learning. No user data is fed into a proprietary AI model for diagnostic purposes. All programme decisions, classification, progression, and session modification are based on deterministic clinical logic reviewed and approved by a licensed physiotherapist.
5. Medical Disclaimer
All content on the Fesera platform is provided for self-guided educational and movement rehabilitation purposes only. It does not constitute medical diagnosis or individual clinical treatment. Always consult a qualified physician if you experience severe symptoms or red flag conditions.
6. Contact for Legal and Compliance
For compliance or legal questions, reach out to our team:
- Legal Notices: legal@fesera.com
- Data Protection: privacy@fesera.com
- Clinical Safety & Support: support@fesera.com